. | SAXA+DAPA+MET . | SAXA+MET . | DAPA+MET . | Total . |
---|---|---|---|---|
n = 179 | n = 176 | n = 179 | N = 534 | |
Age, years | 53 ± 10 | 55 ± 10 | 54 ± 10 | 54 ± 10 |
Women | 94 (53) | 82 (47) | 90 (50) | 266 (50) |
Race | ||||
White | 120 (67) | 121 (69) | 131 (73) | 372 (70) |
African American | 22 (12) | 22 (13) | 16 (9) | 60 (11) |
Asian | 12 (7) | 11 (6) | 10 (6) | 33 (6) |
Other | 25 (14) | 22 (13) | 22 (12) | 69 (13) |
BMI, kg/m2 | 31.8 ± 4.8 | 31.8 ± 5.1 | 31.5 ± 5.3 | 31.7 ± 5.1 |
Duration of diabetes, years | 7.1 ± 5.0 | 8.2 ± 5.5 | 7.4 ± 5.4 | 7.6 ± 5.3 |
HbA1c, % | 8.92 ± 1.18 | 9.03 ± 1.05 | 8.87 ± 1.16 | 8.94 ± 1.13 |
HbA1c, mmol/mol | 74 ± 12.9 | 75 ± 11.5 | 73 ± 12.7 | 74 ± 12.4 |
HbA1c category | ||||
<8% (64 mmol/mol) | 41 (23) | 30 (17) | 41 (23) | 112 (21) |
≥8% and <9% (≥64 and <75 mmol/mol) | 59 (33) | 62 (35) | 61 (34) | 182 (34) |
≥9% (75 mmol/mol) | 79 (44) | 84 (48) | 77 (43) | 240 (45) |
FPG, mg/dL | 180 ± 45.5 | 192 ± 45.3 | 185 ± 48.4 | 186 ± 46.6 |
PPG, mg/dL | 242 ± 54.6 | 256 ± 62.1 | 246 ± 59.4 | 248 ± 58.9 |
Fasting C-peptide, ng/mL | 2.2 ± 1.0 | 2.1 ± 0.90 | 2.2 ± 1.03 | 2.2 ± 0.98 |
eGFR,* mL/min/1.73 m2 | 96.6 ± 19.6 | 92.5 ± 19.5 | 93.9 ± 19.9 | 94.4 ± 19.7 |
. | SAXA+DAPA+MET . | SAXA+MET . | DAPA+MET . | Total . |
---|---|---|---|---|
n = 179 | n = 176 | n = 179 | N = 534 | |
Age, years | 53 ± 10 | 55 ± 10 | 54 ± 10 | 54 ± 10 |
Women | 94 (53) | 82 (47) | 90 (50) | 266 (50) |
Race | ||||
White | 120 (67) | 121 (69) | 131 (73) | 372 (70) |
African American | 22 (12) | 22 (13) | 16 (9) | 60 (11) |
Asian | 12 (7) | 11 (6) | 10 (6) | 33 (6) |
Other | 25 (14) | 22 (13) | 22 (12) | 69 (13) |
BMI, kg/m2 | 31.8 ± 4.8 | 31.8 ± 5.1 | 31.5 ± 5.3 | 31.7 ± 5.1 |
Duration of diabetes, years | 7.1 ± 5.0 | 8.2 ± 5.5 | 7.4 ± 5.4 | 7.6 ± 5.3 |
HbA1c, % | 8.92 ± 1.18 | 9.03 ± 1.05 | 8.87 ± 1.16 | 8.94 ± 1.13 |
HbA1c, mmol/mol | 74 ± 12.9 | 75 ± 11.5 | 73 ± 12.7 | 74 ± 12.4 |
HbA1c category | ||||
<8% (64 mmol/mol) | 41 (23) | 30 (17) | 41 (23) | 112 (21) |
≥8% and <9% (≥64 and <75 mmol/mol) | 59 (33) | 62 (35) | 61 (34) | 182 (34) |
≥9% (75 mmol/mol) | 79 (44) | 84 (48) | 77 (43) | 240 (45) |
FPG, mg/dL | 180 ± 45.5 | 192 ± 45.3 | 185 ± 48.4 | 186 ± 46.6 |
PPG, mg/dL | 242 ± 54.6 | 256 ± 62.1 | 246 ± 59.4 | 248 ± 58.9 |
Fasting C-peptide, ng/mL | 2.2 ± 1.0 | 2.1 ± 0.90 | 2.2 ± 1.03 | 2.2 ± 0.98 |
eGFR,* mL/min/1.73 m2 | 96.6 ± 19.6 | 92.5 ± 19.5 | 93.9 ± 19.9 | 94.4 ± 19.7 |
Data are mean ± SD or n (%).
Calculated by MDRD formula.